NASDAQ:PEP

PepsiCo (PEP)

137.63
-2.39 (1.71%)
as of Sep 4, 2026, 8:00:00 pm Market Open.
235 watching
0
Investor Insights
star iconSep 5, 2026, 12:00 am

This summary was created by AI, based on 10 opinions in the last 12 months.

PepsiCo faces significant challenges, particularly from the emerging GLP-1 weight loss drugs, which are impacting its snack sales and overall demand in North America. Recent reports show that while the company has a robust dividend yield of 4% and has historically performed well due to its strong snack portfolio like Frito-Lay, the current market dynamics have led to a lackluster performance, with a year-to-date decline in stock value compared to competitors like Coke. Despite being downgraded and facing a weakening North American consumer, some experts see potential in the stock if it falls further, labeling it as a buying opportunity. Analysts are divided on its valuation, with opinions suggesting it could be undervalued or fairly valued, reinforcing a cautious approach among investors as they await the upcoming earnings report, which could give clearer insights into its future potential.

consensus icon
Consensus
Caution
valuation icon
Valuation
Undervalued
review icon
Similar
KO

Most recent Opinions go here

Be up to date, don't miss your chance.

BUY

Pays a higher dividend than Coke, and it has a huge snack portfolio, but faces a huge threat from the GLP-1 drugs. Coke is too expensive at 27x PE.

DON'T BUY

Was downgraded today. Demand for Pepsi in North America has been terrible. It's a small position for him. Is -5% this year. Coke is up 20%.

BUY ON WEAKNESS

Faces GLP-1 weight loss drugs, weakening North American consumer and North American business is fading. Valuation is cheap, though. Is attractive if it falls 20-30%.

BUY ON WEAKNESS

Last quarter they reported super numbers which sent shares soaring. But the market rotation has knocked shares back to that starting point. The dividend now pays 4%. This is a buying opportunity.

SELL

It is part of the consumer staples sector and is not popular since its products are not considered healthy, especially those with high levels of sugar. There are better opportunities elsewhere in the sector. There is a shift to more healthy products.

BUY

They report Thursday. He's impressed by how they've dealt with the rise of GLP-1 drugs and healthy diets among the young. The CEO listens to customers.

COMMENT

 It reports Tuesday. He worries about it because of its snack division which has been struggling against the weight-loss drugs. Shares moved up today.

DON'T BUY

They report Thursday. They've had it tough lately, but have a strong Frito-Lay snack franchise. Also pays a solid 4% dividend. However, the younger generation is watching their health, and people are taking weight-loss drugs, GLP-1 which diminishes cravings. PEP is -7% this year vs. Coke +7%.

BUY

Pays a safe 4% yield. Shares are bottoming now. Own, don't trade.

BUY

Remains a premium growth company. Elliott Management just took a big stake, and he likes this activist firm. Shares are 7 points below before Elliott stepped in--a bargain. Also, this yields almost 4% because shares have fallen so much.

DON'T BUY

It reports Thursday. It trades at a low 17x PE. Headwinds: GLP-1 drugs, RFJ Jr. who despises junk food though embraces junk science, and the desire to stay healthy. It's a tough industry.

DON'T BUY

He sold in 2024 when the valuation started looking a bit full. When pandemic inflation hit, "elasticity" was low so that consumers kept buying despite higher prices. Cumulative effect of inflation caught up to them. Not tempted, given slowing macro economy and inflation genie not fully back in the bottle.

HOLD

Operates in a cola duopoly with KO, good job creating shareholder value. He likes market leaders like these that have little to no direct competition, so this name fits that bill. That being said, it's a lot harder these days with consumer brands to establish a brand and build a moat. Today he could launch a cola company online, using Instagram and FB, with very little cost and effort, and with luck it could even go viral. Brands will have a tough time. 

Very strong, well-established brand. PEP got into snacks, which are up against healthier lifestyles. He owns FEVR, take a look at that one.

DON'T BUY

An amazing company and major soft drinks maker. Shares are far from its last highs, so low that the dividend now pays 4.42%. Suppose RFK Jr. goes after companies that produce caloric snacks? Share are very undervalued, but who knows when shares will stop going down?

BUY

Yields 4%, well-run and can start a position at 16x PE. They will right the ship. 

Showing 1 to 15 of 200 entries

PepsiCo (PEP) Frequently Asked Questions

What is PepsiCo stock symbol?

PepsiCo is a American stock, trading under the symbol PEP (previously PEP-Q on Stockchase) on the NASDAQ (PEP). It is usually referred to as NASDAQ:PEP or PEP

Is PepsiCo a buy or a sell?

In the last year, 9 stock analysts issued a Buy, Sell, or Hold rating on PEP (previously PEP-Q on Stockchase). 6 analysts recommended to BUY and 3 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for PepsiCo.

Is PepsiCo a good investment or a top pick?

PepsiCo was recommended as a Top Pick by Jenny Harrington, CEO, Gilman Hill Asset Management on 2026-08-21. Read the latest stock experts ratings for PepsiCo.

Why is PepsiCo stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for PepsiCo.

Is PepsiCo worth watching?

PepsiCo is followed by 235 investors on Stockchase and is a trending stock that is worth watching.

What is PepsiCo stock price?

On 2026-09-04, PepsiCo (PEP) stock closed at a price of $137.63.

Star iconStar iconStar iconStar half iconStar empty icon
3.7(9)
Based on 9 expert opinions: 6 buy 0 hold 3 sell